Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 1,000 shares at $2.00 ($2,000)
  5. 4/A Open-market buy Director bought 5,000 shares at $1.96 ($9,806)
  6. 4 Open-market buy Director bought 5,000 shares at $1.96 ($9,806)
  7. 4 Open-market buy Director bought 5,000 shares at $2.02 ($10,100)
  8. 4 Grant or award President and CEO acquired 8,251 shares (grant or award)
  9. 4 Open-market sale 10% owner sold 10,000 shares at $2.10 ($21,000)
  10. 4 Grant or award President and CEO acquired 8,052 shares (grant or award)
  11. 4 Grant or award President and CEO acquired 7,407 shares (grant or award)
  12. 4/A Open-market buy Director bought 5,000 shares at $2.28 ($11,400)
  13. 4 Open-market buy Director bought 5,000 shares at $2.28 ($11,400)
  14. 4 Open-market buy Director bought 5,000 shares at $2.34 ($11,700)
  15. 4 Open-market sale 10% owner sold 10,000 shares at $2.37 ($23,700)
  16. 4 Grant or award President and CEO acquired 6,337 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 5,828 shares (grant or award)
  18. 4 Open-market sale 10% owner sold 10,000 shares at $3.19 ($31,900)
  19. 4 Open-market buy Director bought 2,000 shares at $3.17 ($6,340)
  20. 4 Grant or award President and CEO acquired 5,258 shares (grant or award)

Page 11 of 39 · 776 filings